핵의학

본문글자크기
  • 2015년 09월호
    Pituitary 18F-FDG Uptake Correlates With Serum TSH Levels in Subjects With Diffuse Thyroid 18F-FDG Uptake

    연세의대 / 정용휴, 윤미진*

  • 출처
    Clin Nucl Med
  • 등재일
    2015 Aug
  • 저널이슈번호
    40(8):632-6
  • 내용

    바로가기  >

     

    [Abstract]

    PURPOSE:

    This study was to evaluate the relationship among FDG uptake in the pituitary gland (FDGp), FDG uptake in the thyroid gland (FDGt), and serum thyroid-stimulating hormone (TSH) levels in patients with diffuse FDGt incidentally noted on positron emission tomography/computed tomography (PET/CT).

    PATIENTS AND METHODS:

    We retrospectively reviewed FDG PET/CT scans of 2,945 subjects who underwent health screening. Of these, 44 subjects had diffuse FDGt and available thyroid function tests. FDGt and FDGp were correlated with serum TSH. FDGp in 44 paired control subjects without FDGt and 15 thyroid cancer patients undergoing thyroid hormone withdrawal were additionally measured, and compared with FDGp in the 44 subjects with FDGt divided into 3 groups according to serum TSH levels.

    RESULTS:

    In the 44 subjects, there was a strong correlation found between FDGp and TSH (P < 0.001, r = 0.618). As well, there were statistically significant differences in FDGp between the low, normal, and high TSH groups (P < 0.001). FDGp in the paired control subjects was not different from that in the normal TSH group (P = 0.384), and FDGp in the TSH-stimulated thyroid cancer patients was not different from that in the high TSH group (P = 0.463).

    CONCLUSION:

    We found a strong positive correlation between pituitary FDG uptake and serum TSH. Pituitary FDG uptake seems to hold an important clue to the functional status of the thyroid in subjects with diffuse thyroid FDG uptake. Furthermore, physiologic FDG uptake in the pituitary gland caused by hypothyroidism should not be confused with pathologic conditions such as macroadenoma or metastases. 

     

     

     

    [Author information]

    Jeong YH1, Kim D, Lee JW, Rhee Y, Nam KH, Yun M, Kim CK.

     

    1From the *Department of Nuclear Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea; †Yonsei University College of Medicine, Seoul, Korea; ‡Department of Internal Medicine, Severance Hospital, Endocrine Research Institute, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea; §Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea; and ∥Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

  • 덧글달기
    덧글달기
       IP : 3.145.9.12

    등록